Clinical trial of Carperitide and Torasemide (HANSAM therapy) in cardiac surgery (HANSAM trial).
Not Applicable
- Conditions
- valve disease, thoracic aortic aneurysm, angina, myocardial infarction et.al.
- Registration Number
- JPRN-UMIN000013654
- Lead Sponsor
- ihon University Itabashi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
cardiogenic shock hemodiaisis Doctor's decision not to register to this regimen
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rine volume
- Secondary Outcome Measures
Name Time Method 1) BNP 3) renin activity, angiotensin-II, aldsterone 4) CK-MB, Tp-I, H-FABP 5) serum creatinine (sCr) 6) mortality, complication 7) postoperative death (early, late) 8) MACCE